Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma

Head and Neck

Volumn 37, Issue 4, 2015, Pages 518-523

  Gore, Sinclair M ^a,c   Crombie, Anthony K ^b   Batstone, Martin D ^b   Clark, Jonathan R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

chemoradiotherapy; feeding tube; head and neck cancer; organ preservation; osteoradionecrosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN;

ADULT; AGED; ANTEROLATERAL THIGH FLAP; BONE NECROSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; ENTERIC FEEDING; FEMALE; FIBULA GRAFT; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; HEAD AND NECK NEOPLASMS; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; ENTERAL NUTRITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925387738     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23626     Document Type: Conference Paper

References (15)

1. Zuydam AC, Lowe D, Brown JS, Vaughan ED, Rogers SN,. Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin Otolaryngol 2005; 30: 428-437.
2. Williamson JS, Ingrams D, Jones H,. Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study. Ann R Coll Surg Engl 2011; 93: 591-595.
3. [No authors listed]. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
4. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21: 92-98.
5. Borggreven PA, Verdonck-de Leeuw I, Langendijk JA, et al. Speech outcome after surgical treatment for oral and oropharyngeal cancer: a longitudinal assessment of patients reconstructed by a microvascular flap. Head Neck 2005; 27: 785-793.
6. Borggreven PA, Verdonck-de Leeuw I, Rinkel RN, et al. Swallowing after major surgery of the oral cavity or oropharynx: a prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction. Head Neck 2007; 29: 638-647.
7. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76.
8. Mouw KW, Haraf DJ, Stenson KM, et al. Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2010; 136: 1226-1234.
9. van de Pol M, Levendag PC, de Bree RR, et al. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. Brachytherapy 2004; 3: 78-86.
10. Walvekar RR, Li RJ, Gooding WE, et al. Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx. Laryngoscope 2008; 118: 2129-2134.
11. Pederson AW, Salama JK, Witt ME, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer. Am J Clin Oncol 2011; 34: 356-361.
12. Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx. Cancer 2000; 89: 939-945.
13. Crombie AK, Farah C, Tripcony L, Dickie G, Batstone MD,. Primary chemoradiotherapy for oral cavity squamous cell carcinoma. Oral Oncol 2012; 48: 1014-1018.
14. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP,. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007; 14: 1449-1457.
15. Soo KC, Tan EH, Wee J, et al. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison. Br J Cancer 2005; 93: 279-286.